We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Brivaracetam

Australian Public Assessment Report

AusPAR

AusPAR Brivaracetam [PDF, 2.15 MB]

AusPAR Brivaracetam [Word, 3.62 MB]

Attachment: Product Information Brivaracetam [PDF, 271.02 KB]

Attachment: Product Information Brivaracetam [Word, 313.5 KB]

Attachment: Product Information Brivaracetam [PDF, 270.63 KB]

Attachment: Product Information Brivaracetam [Word, 315 KB]

Attachment: Extract from Clinical Evaluation Report: Brivaracetam [PDF, 1.77 MB]

Attachment: Extract from Clinical Evaluation Report: Brivaracetam [Word, 2.54 MB]

Device/Product Name

Briviact

Active ingredients

Brivaracetam

AusPAR Date

7 March 2017

Published

11 April 2017

Submission Number

PM-2015-01568-1-1

Submission Type

New biological entity

Decision

Approved